GO:0060755 negative regulation of mast cell chemotaxis: Signaling Checkpoints, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060755 describes any process that decreases the rate, frequency or extent of mast cell chemotaxis, the directed movement of a mast cell toward an external stimulus.
• Negative regulation of mast cell chemotaxis is a biological_process that acts as a brake on mast cell recruitment, preventing excessive tissue infiltration in allergic and inflammatory settings.
• CXCL1 acts as a negative regulator of mast cell chemotaxis to airway smooth muscle cell products in vitro, showing that chemokine networks can suppress as well as promote mast cell migration.
• Transmembrane adaptor proteins such as PAG/CBP and CD72 provide inhibitory signaling checkpoints that limit mast cell activation and migratory responses.
• Ceramide binding to CD300f inhibits lipopolysaccharide-induced skin inflammation, linking lipid-sensing inhibitory receptors to control of mast cell-dependent inflammation.
• Proteolytic regulation by neutrophil proteinase 3 and mast cell chymase modulates chemerin activity, illustrating how protease networks can indirectly restrain mast cell chemotaxis.
Description
Mast cells are tissue-resident immune cells that migrate toward external stimuli in a process called mast cell chemotaxis. GO:0060755, negative regulation of mast cell chemotaxis, is the biological process that decreases the rate, frequency or extent of this directed movement. Because unchecked mast cell recruitment contributes to allergic inflammation and tissue remodeling, understanding the molecular brakes on chemotaxis is essential for therapeutic development. The QuickGO definition frames the term as any process that reduces mast cell chemotaxis, which includes inhibitory receptors, soluble chemokine decoys, and protease-mediated modulation of chemoattractants. Research on negative regulation of mast cell chemotaxis has revealed that inhibitory signaling adaptors such as PAG/CBP and CD72 can dampen mast cell activation and down-regulate KIT and FcεRIα expression, indirectly limiting migratory capacity. In parallel, chemokine CXCL1 acts as a negative regulator of mast cell chemotaxis to airway smooth muscle cell products in vitro, demonstrating that specific chemokines can suppress rather than promote migration. These findings position GO:0060755 as a critical counterbalance to pro-migratory signals in the tissue microenvironment. For researchers, GO:0060755 provides a framework to study how inhibitory receptors, proteases, and lipid mediators converge to control mast cell positioning. Defects in these negative regulatory pathways may underlie primary atopic disorders and chronic inflammatory diseases, making the term relevant to both basic immunology and clinical genomics. This article synthesizes the authoritative QuickGO definition with verified PubMed literature to outline the mechanisms, key genes, disease links, and experimental models for studying negative regulation of mast cell chemotaxis.
negative regulation of mast cell chemotaxis At A Glance
| GO ID | GO:0060755 |
|---|---|
| GO term | negative regulation of mast cell chemotaxis |
| Ontology | biological_process |
| Synonym | none |
| Major function | Decreases the rate, frequency or extent of mast cell chemotaxis, the directed movement of a mast cell in response to an external stimulus. |
| Related process | Mast cell chemotaxis (positive regulation of directed migration) |
| Cellular context | Mast cells in tissues such as skin, airway smooth muscle, and connective tissue |
| Key inhibitory molecules | CXCL1, PAG/CBP, CD72, CD300f, neutrophil proteinase 3, mast cell chymase |
| Disease relevance | Allergic inflammation, atopic disorders, skin inflammation, innate immunity against gram-negative bacteria |
What Is GO:0060755?
GO:0060755, negative regulation of mast cell chemotaxis, is defined by QuickGO as any process that decreases the rate, frequency or extent of mast cell chemotaxis. Mast cell chemotaxis itself is the movement of a mast cell in response to an external stimulus. In practical terms, this GO term covers molecular events that put the brakes on directed mast cell migration, including inhibitory receptor signaling, chemokine sequestration, and protease-mediated degradation of chemoattractants.
Why Is negative regulation of mast cell chemotaxis Important in Cell Biology?
Negative regulation of mast cell chemotaxis is important because it prevents excessive mast cell accumulation in tissues, which would otherwise amplify allergic and inflammatory responses. Inhibitory receptors such as CD72 and PAG/CBP down-regulate mast cell function and expression of KIT and FcεRIα, thereby limiting both activation and migratory potential. Soluble factors like CXCL1 can directly suppress mast cell chemotaxis to airway smooth muscle products, providing a layer of local control in the lung. Dysregulation of these brakes may contribute to primary atopic disorders and chronic skin inflammation, making GO:0060755 a valuable term for understanding disease mechanisms and identifying therapeutic targets.
• Prevents excessive mast cell infiltration into tissues, which is a hallmark of allergic inflammation.
• Provides inhibitory checkpoints through receptors such as CD72 and PAG/CBP that down-regulate KIT and FcεRIα.
• Links chemokine networks to suppression of mast cell migration, as shown for CXCL1 in airway smooth muscle models.
• Connects lipid-sensing receptors like CD300f to control of mast cell-dependent skin inflammation.
• Highlights protease-mediated regulation of chemoattractants by neutrophil proteinase 3 and mast cell chymase.
• Relevant to primary atopic disorders, where genomic sequencing can identify defects in regulatory pathways.
• Informs development of therapies that enhance negative regulation to treat chronic inflammatory diseases.
• Provides a conceptual counterbalance to pro-migratory signals in mast cell biology.
• Supports research on innate immunity, as JAK3-dependent mast cell functions are critical for defense against gram-negative bacteria.
• Offers a framework for CRISPR-based dissection of inhibitory signaling components in mast cells.
What Happens During negative regulation of mast cell chemotaxis?
Inhibitory Receptor Signaling Checkpoints
In simple terms: Certain receptors on the mast cell surface act like brakes, sending signals that stop the cell from moving.
Transmembrane adaptor proteins and inhibitory receptors set thresholds that limit mast cell activation and migration. PAG/CBP is involved in both positive and negative regulation of mast cell signaling, indicating that it can dampen activating pathways that would otherwise promote chemotaxis. CD72 negatively regulates mouse mast cell functions and down-regulates the expression of KIT and FcεRIα, thereby reducing the cell's responsiveness to growth and activation signals that support migration. These checkpoints ensure that mast cells do not over-respond to external stimuli.
Chemokine-Mediated Suppression
In simple terms: Some chemokines tell mast cells to stop moving instead of attracting them.
CXCL1 acts as a negative regulator of mast cell chemotaxis to airway smooth muscle cell products in vitro, demonstrating that specific chemokines can suppress directed migration. This contrasts with classical chemoattractants and shows that the chemokine network contains both positive and negative regulators of mast cell positioning. The balance between attractant and repellent signals determines the net migratory response in tissues such as the airway.
Lipid and Ceramide Sensing
In simple terms: Fat-like molecules can bind to receptors that shut down inflammation and movement.
Ceramide-CD300f binding inhibits lipopolysaccharide-induced skin inflammation, linking lipid-sensing inhibitory receptors to control of mast cell-dependent inflammatory responses. This pathway provides a mechanism by which endogenous lipids can restrain mast cell activation and, indirectly, chemotaxis. The involvement of CD300f highlights the importance of lipid mediators in negative regulation of mast cell function.
Protease-Mediated Modulation of Chemoattractants
In simple terms: Enzymes that cut proteins can destroy or change the signals that attract mast cells.
Neutrophil proteinase 3 and mast cell chymase play roles in chemerin proteolytic regulation, which can alter the availability of active chemoattractants. By cleaving or modifying chemokines, these proteases can reduce the strength of migratory signals and thus contribute to negative regulation of mast cell chemotaxis. This mechanism adds an extracellular layer of control over mast cell recruitment.
Microtubule and Cytoskeletal Control
In simple terms: The cell's internal skeleton must be reorganized for movement, and regulatory proteins can interfere with this process.
Regulation of microtubule nucleation in mouse bone marrow-derived mast cells by ARF GTPase-activating protein GIT2 provides insight into how cytoskeletal dynamics are controlled during mast cell responses. Although direct evidence for GIT2 in negative regulation of chemotaxis is limited, microtubule reorganization is a prerequisite for directed migration, and proteins that modulate nucleation can influence the efficiency of movement. This subsection highlights the cytoskeletal layer that can be targeted to suppress chemotaxis.
Key Genes Involved in GO:0060755 negative regulation of mast cell chemotaxis
The following genes and proteins have been implicated in negative regulation of mast cell chemotaxis or related inhibitory pathways in mast cells.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CXCL1 | Negative regulator of mast cell chemotaxis to airway smooth muscle cell products | Studied in vitro to understand chemokine-mediated suppression of migration |
| PAG/CBP | Transmembrane adaptor involved in both positive and negative regulation of mast cell signaling | Provides a model for inhibitory signaling checkpoints |
| CD72 | Negatively regulates mouse mast cell functions and down-regulates KIT and FcεRIα | Inhibitory receptor that limits mast cell activation and migratory potential |
| CD300f | Ceramide-binding inhibitory receptor that inhibits LPS-induced skin inflammation | Links lipid sensing to negative regulation of mast cell-dependent inflammation |
| KIT | Receptor tyrosine kinase down-regulated by CD72 | Its expression level affects mast cell survival and migration |
| FCER1A | High-affinity IgE receptor alpha chain down-regulated by CD72 | Modulates mast cell activation and downstream migratory responses |
| JAK3 | Janus kinase 3 required for mast cell-mediated innate immunity | Shows the importance of signaling pathways in mast cell function |
| GIT2 | ARF GTPase-activating protein regulating microtubule nucleation | Potential role in cytoskeletal control of mast cell migration |
| PRTN3 | Neutrophil proteinase 3 involved in chemerin proteolytic regulation | Modulates chemoattractant availability |
| CMA1 | Mast cell chymase involved in chemerin proteolytic regulation | Protease that can alter chemokine signals |
| CHEMERIN | Chemerin chemoattractant regulated by proteases | Its processing affects mast cell recruitment |
| ARF6 | ARF GTPase family member potentially regulated by GIT2 | Cytoskeletal and membrane trafficking in mast cells |
| RAC1 | Rho GTPase involved in cell migration | Downstream of inhibitory signals that suppress chemotaxis |
| CDC42 | Rho GTPase involved in cell migration | Potential target of negative regulatory pathways |
| PI3K | Phosphoinositide 3-kinase in mast cell signaling | Can be modulated by inhibitory receptors |
| SHP-1 | Protein tyrosine phosphatase that can inhibit mast cell signaling | Potential mediator of negative regulation |
| SHIP-1 | Inositol phosphatase that dampens mast cell activation | Inhibitory signaling component |
How Is negative regulation of mast cell chemotaxis Regulated?
Negative regulation of mast cell chemotaxis is itself controlled by a network of inhibitory receptors, soluble chemokines, and proteases. PAG/CBP can both positively and negatively regulate mast cell signaling, indicating that its activity is context-dependent and subject to feedback. CD72 down-regulates KIT and FcεRIα expression, which reduces the cell's sensitivity to growth and activation signals that promote migration. CXCL1 provides an external brake by suppressing chemotaxis to airway smooth muscle products. Ceramide-CD300f binding inhibits LPS-induced skin inflammation, showing that lipid mediators can activate inhibitory pathways. Proteases such as neutrophil proteinase 3 and mast cell chymase regulate chemerin, thereby controlling the availability of a chemoattractant. Together, these layers ensure that mast cell migration is tightly regulated.
negative regulation of mast cell chemotaxis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CD72 | Atopic disorders and mast cell hyperactivation | Cd72 knockout mouse mast cells |
| CD300f | Skin inflammation | CD300f knockout mouse model of LPS-induced skin inflammation |
| CXCL1 | Airway remodeling and asthma | In vitro mast cell chemotaxis assays with airway smooth muscle products |
| JAK3 | Innate immunity against gram-negative bacteria | Jak3 knockout mouse model of infection |
| PAG/CBP | Mast cell signaling dysregulation | PAG/CBP knockout mast cells |
Allergic Inflammation and Atopic Disorders
Defects in negative regulation of mast cell chemotaxis may contribute to excessive mast cell accumulation in allergic tissues. Primary atopic disorders can be identified by clinical landmark-guided genomic sequencing, which may reveal mutations in inhibitory pathways. CD72 down-regulates KIT and FcεRIα, and loss of this brake could enhance mast cell activation and migration in atopic disease.
Skin Inflammation
Ceramide-CD300f binding inhibits lipopolysaccharide-induced skin inflammation, linking negative regulation of mast cell function to protection against inflammatory skin disease. Impaired CD300f signaling could lead to unchecked mast cell responses and worsened skin inflammation.
Innate Immunity and Infection
JAK3 is required for mast cell-mediated innate immunity against gram-negative bacteria, showing that mast cell functions are critical for host defense. Negative regulation of chemotaxis must be balanced to allow sufficient mast cell recruitment to infection sites while preventing excessive inflammation.
Airway Remodeling
CXCL1 negatively regulates mast cell chemotaxis to airway smooth muscle cell products, suggesting that this pathway may protect against mast cell accumulation in airway remodeling. Dysregulation could contribute to asthma and other airway diseases.
From negative regulation of mast cell chemotaxis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CD72 enhance mast cell chemotaxis? | CD72 knockout mouse mast cells |
| Does CXCL1 suppress mast cell migration in vitro? | Mast cell chemotaxis assays with CXCL1 |
| Does CD300f mediate ceramide-dependent inhibition of skin inflammation? | CD300f knockout mouse model |
| Is PAG/CBP a negative regulator of mast cell signaling? | PAG/CBP knockout mast cells |
| Does GIT2 regulate microtubule nucleation during mast cell migration? | GIT2 knockdown or knockout mast cells |
| Does JAK3 deficiency impair mast cell innate immunity? | Jak3 knockout mice |
How to Study the negative regulation of mast cell chemotaxis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transwell chemotaxis assay | Directed migration of mast cells | Testing CXCL1 as a negative regulator |
| CRISPR-Cas9 knockout | Loss-of-function of candidate genes | Generating CD72 or PAG/CBP knockout mast cells |
| Immunoblotting | Protein expression and phosphorylation | Measuring KIT and FcεRIα down-regulation by CD72 |
| Protease activity assay | Chemerin cleavage by proteases | Studying neutrophil proteinase 3 and chymase |
| Microtubule nucleation assay | Cytoskeletal dynamics | Investigating GIT2 function in mast cells |
| Flow cytometry | Surface receptor expression | Quantifying FcεRIα and KIT levels |
| Mouse infection model | Innate immunity against gram-negative bacteria | Testing JAK3-dependent mast cell functions |
| Genomic sequencing | Identification of mutations in atopic disorders | Diagnosing primary atopic disorders |
In Vitro Chemotaxis Assays
Transwell or microfluidic chemotaxis assays measure the directed movement of mast cells toward or away from stimuli. These assays were used to show that CXCL1 negatively regulates mast cell chemotaxis to airway smooth muscle cell products. They are essential for quantifying the rate and extent of migration under controlled conditions.
Genetic Knockout and Knockdown
Knockout or knockdown of candidate genes such as CD72, PAG/CBP, or GIT2 in mast cells allows researchers to test whether these molecules are required for negative regulation of chemotaxis. CRISPR-Cas9 is a powerful tool for generating these models.
Signaling Pathway Analysis
Phospho-specific antibodies and immunoblotting can reveal changes in KIT, FcεRIα, and downstream kinases such as JAK3. These methods help define the molecular mechanisms by which inhibitory receptors dampen migratory signals.
Protease Activity Assays
Enzymatic assays for neutrophil proteinase 3 and mast cell chymase can measure chemerin processing and its impact on chemoattractant availability. Such assays link protease networks to negative regulation of mast cell chemotaxis.
How CRISPR Can Be Used to Study GO:0060755 negative regulation of mast cell chemotaxis
Knockout
CRISPR knockout of genes such as CD72, PAG/CBP, or GIT2 in mast cell lines or primary cells can reveal their role in negative regulation of chemotaxis. For example, CD72 knockout would test whether loss of this inhibitory receptor enhances migration. PAG/CBP knockout can dissect its dual role in mast cell signaling.
Point Mutation
Point mutations can be introduced to mimic patient variants or to abrogate specific phosphorylation sites in inhibitory receptors. This approach can test whether a single amino acid change in CD300f or PAG/CBP alters negative regulation of mast cell chemotaxis.
Knock-in
Knock-in of tagged versions of inhibitory receptors or chemokines allows real-time tracking of their localization and interactions. For example, a fluorescently tagged CXCL1 could be used to study its suppressive effects on mast cell migration.
Overexpression
Overexpression of negative regulators such as CXCL1 or CD72 in mast cells or surrounding tissues can enhance the suppression of chemotaxis. This strategy can validate the sufficiency of a candidate gene to inhibit migration.
How EDITGENE Supports negative regulation of mast cell chemotaxis Research
Researchers studying negative regulation of mast cell chemotaxis-related genes often need to determine whether a candidate gene is causally involved in suppressing migration or is merely correlated with the phenotype. EDITGENE provides CRISPR-based cell model services to enable precise genetic dissection of these pathways.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of mast cell chemotaxis research.
Frequently Asked Questions About negative regulation of mast cell chemotaxis
What is negative regulation of mast cell chemotaxis?
It is the biological process that decreases the rate, frequency or extent of mast cell chemotaxis, the directed movement of a mast cell in response to an external stimulus, as defined by GO:0060755.
What genes are involved in negative regulation of mast cell chemotaxis?
Key genes include CXCL1, PAG/CBP, CD72, CD300f, and proteases such as neutrophil proteinase 3 and mast cell chymase.
How does CXCL1 inhibit mast cell chemotaxis?
CXCL1 acts as a negative regulator of mast cell chemotaxis to airway smooth muscle cell products in vitro, suppressing directed migration.
What is the role of CD72 in mast cells?
CD72 negatively regulates mouse mast cell functions and down-regulates the expression of KIT and FcεRIα, reducing activation and migratory potential.
How does CD300f affect skin inflammation?
Ceramide-CD300f binding inhibits lipopolysaccharide-induced skin inflammation, linking this inhibitory receptor to control of mast cell-dependent inflammation.
What is the function of PAG/CBP in mast cell signaling?
PAG/CBP is a transmembrane adaptor protein involved in both positive and negative regulation of mast cell signaling.
How do proteases regulate mast cell chemotaxis?
Neutrophil proteinase 3 and mast cell chymase participate in chemerin proteolytic regulation, which can alter chemoattractant availability and suppress migration.
What diseases are linked to defective negative regulation of mast cell chemotaxis?
Primary atopic disorders, skin inflammation, and airway remodeling may involve defects in these inhibitory pathways.
What experimental models are used to study negative regulation of mast cell chemotaxis?
Transwell chemotaxis assays, CRISPR knockout mast cells, and mouse models of inflammation are commonly used.
How can CRISPR help study negative regulation of mast cell chemotaxis?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise testing of candidate genes for their role in suppressing mast cell migration.
Conclusion
GO:0060755, negative regulation of mast cell chemotaxis, is a critical biological process that restrains mast cell recruitment and prevents excessive inflammation. Key inhibitory molecules such as CXCL1, CD72, PAG/CBP, and CD300f provide multiple layers of control. Dysregulation of these pathways is linked to atopic disorders, skin inflammation, and airway remodeling, making them attractive therapeutic targets. Researchers can leverage CRISPR-based knockout, point mutation, knock-in, and overexpression models to dissect these mechanisms with precision. EDITGENE offers comprehensive services to accelerate discovery in this field, from library screening to bioinformatics analysis.
References
- 1. Niehues T et al.. 2024. Rapid identification of primary atopic disorders (PAD) by a clinical landmark-guided, upfront use of genomic sequencing.. Allergol Select 8:304-323 PMID: 39381601
- 2. Sulimenko V et al.. 2024. Regulation of microtubule nucleation in mouse bone marrow-derived mast cells by ARF GTPase-activating protein GIT2.. Front Immunol 15:1321321 PMID: 38370406
- 3. Draberova L et al.. 2014. Transmembrane adaptor protein PAG/CBP is involved in both positive and negative regulation of mast cell signaling.. Mol Cell Biol 34(23):4285-300 PMID: 25246632
- 4. Alkhouri H et al.. 2014. CXCL1 is a negative regulator of mast cell chemotaxis to airway smooth muscle cell products in vitro.. Clin Exp Allergy 44(3):381-92 PMID: 24588865
- 5. Kataoka TR et al.. 2015. CD72 negatively regulates mouse mast cell functions and down-regulates the expression of KIT and FcεRIα.. Int Immunol 27(2):95-103 PMID: 25239131
- 6. Shiba E et al.. 2017. Ceramide-CD300f Binding Inhibits Lipopolysaccharide-induced Skin Inflammation.. J Biol Chem 292(7):2924-2932 PMID: 28073916
- 7. Guillabert A et al.. 2008. Role of neutrophil proteinase 3 and mast cell chymase in chemerin proteolytic regulation.. J Leukoc Biol 84(6):1530-8 PMID: 18753310
- 8. Malaviya R et al.. 2001. Role of Janus kinase 3 in mast cell-mediated innate immunity against gram-negative bacteria.. Immunity 15(2):313-21 PMID: 11520465
